Michael Morneau - Net Worth and Insider Trading
Michael Morneau Net Worth
The estimated net worth of Michael Morneau is at least $6 Million dollars as of 2024-11-13. Michael Morneau is the VP, Finance and Administration of Viking Therapeutics Inc and owns about 94,035 shares of Viking Therapeutics Inc (VKTX) stock worth over $6 Million. Details can be seen in Michael Morneau's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Morneau has not made any transactions after 2018-05-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Morneau
Michael Morneau Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Morneau owns 1 companies in total, including Viking Therapeutics Inc (VKTX) .
Click here to see the complete history of Michael Morneau’s form 4 insider trades.
Insider Ownership Summary of Michael Morneau
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| VKTX | Viking Therapeutics Inc | 2018-05-31 | Chief Financial Officer |
Michael Morneau Latest Holdings Summary
Michael Morneau currently owns a total of 1 stock. Michael Morneau owns 94,035 shares of Viking Therapeutics Inc (VKTX) as of May 31, 2018, with a value of $6 Million.
Latest Holdings of Michael Morneau
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| VKTX | Viking Therapeutics Inc | 2018-05-31 | 94,035 | 60.61 | 5,699,461 |
Holding Weightings of Michael Morneau
Michael Morneau Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Morneau has made a total of 0 transactions in Viking Therapeutics Inc (VKTX) over the past 5 years. The most-recent trade in Viking Therapeutics Inc is the sale of 21,551 shares on May 31, 2018, which brought Michael Morneau around $199,347.
Insider Trading History of Michael Morneau
- 1
Michael Morneau Trading Performance
Michael Morneau Ownership Network
Ownership Network List of Michael Morneau
Ownership Network Relation of Michael Morneau
Michael Morneau Owned Company Details
What does Viking Therapeutics Inc do?
Who are the key executives at Viking Therapeutics Inc?
Michael Morneau is the Chief Financial Officer of Viking Therapeutics Inc. Other key executives at Viking Therapeutics Inc include Chief Financial Officer Greg Zante , director & President & CEO Brian Lian , and Chief Operating Officer Marianna Mancini .
Viking Therapeutics Inc (VKTX) Insider Trades Summary
Over the past 18 months, Michael Morneau made no insider transaction in Viking Therapeutics Inc (VKTX). Other recent insider transactions involving Viking Therapeutics Inc (VKTX) include a net sale of 879,938 shares made by Brian Lian , a net sale of 68,786 shares made by J Matthew Singleton , and a net sale of 229,579 shares made by Greg Zante .
In summary, during the past 3 months, insiders sold 543,473 shares of Viking Therapeutics Inc (VKTX) in total and bought 0 shares, with a net sale of 543,473 shares. During the past 18 months, 1,601,754 shares of Viking Therapeutics Inc (VKTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,601,754 shares.
Viking Therapeutics Inc (VKTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Viking Therapeutics Inc Insider Transactions
Michael Morneau Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Morneau. You might contact Michael Morneau via mailing address: C/o Trius Therapeutics, Inc., 6410 Nancy Ridge Drive, Suite 101, San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
